Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Can Short Bouts of Exercise ("Exercise Snacks") Improve Body Composition in Adolescents with Type 1 Diabetes? A Feasibility Study.

Hasan R, Perez-Santiago D, Churilla JR, Montes B, Hossain J, Mauras N, Darmaun D.

Horm Res Paediatr. 2020 Jan 31:1-9. doi: 10.1159/000505328. [Epub ahead of print]

PMID:
32007996
2.

Executive task-based brain function in children with type 1 diabetes: An observational study.

Foland-Ross LC, Buckingam B, Mauras N, Arbelaez AM, Tamborlane WV, Tsalikian E, Cato A, Tong G, Englert K, Mazaika PK, Reiss AL; Diabetes Research in Children Network (DirecNet).

PLoS Med. 2019 Dec 9;16(12):e1002979. doi: 10.1371/journal.pmed.1002979. eCollection 2019 Dec.

3.

Psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire in a randomized open-label comparator trial in idiopathic short stature.

Bloemeke J, Balacano Valdez R, Mauras N, Mericq V, Ross J, Permuy J, Quitmann J, Bullinger M.

J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1089-1101. doi: 10.1515/jpem-2019-0137.

PMID:
31557127
4.

Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors.

Bullinger M, Bloemeke J, Mericq V, Sommer R, Gaete X, Ross JL, Yu YM, Permuy J, Gagliardi P, Damaso YL, Mauras N.

Horm Res Paediatr. 2018;90(6):381-392. doi: 10.1159/000496353. Epub 2019 Feb 28.

PMID:
30820008
5.

Impact of Early Diabetic Ketoacidosis on the Developing Brain.

Aye T, Mazaika PK, Mauras N, Marzelli MJ, Shen H, Hershey T, Cato A, Weinzimer SA, White NH, Tsalikian E, Jo B, Reiss AL; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2019 Mar;42(3):443-449. doi: 10.2337/dc18-1405. Epub 2018 Dec 20.

PMID:
30573652
6.

Glutamine and type 1 diabetes mellitus: is there a role in glycemic control?

Darmaun D, Torres-Santiago L, Mauras N.

Curr Opin Clin Nutr Metab Care. 2019 Jan;22(1):91-95. doi: 10.1097/MCO.0000000000000530. Review.

PMID:
30461450
7.

Is There a Difference between Ultrasonographic (US) Uterine Changes of Oral Versus Transdermal (TD) 17β Estradiol (17β E2) in Girls with Turner Syndrome (TS)? Own Experience and Literature Review.

Kraus J, Unanue N, Espinoza A, Iniguez G, Torres-Santiago L, Singh R, Mauras N, Mericq V.

Pediatr Endocrinol Rev. 2018 Sep;16(1):178-185. doi: 10.17458/per.vol16.2018.kue.uschangesversustd.

PMID:
30371036
8.

Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome.

Mauras N, Torres-Santiago L, Santen R, Mericq V, Ross J, Colon-Otero G, Damaso L, Hossain J, Wang Q, Mesaros C, Blair IA.

Clin Endocrinol (Oxf). 2019 Jan;90(1):155-161. doi: 10.1111/cen.13869. Epub 2018 Oct 25.

PMID:
30281805
9.

Longitudinal assessment of hippocampus structure in children with type 1 diabetes.

Foland-Ross LC, Reiss AL, Mazaika PK, Mauras N, Weinzimer SA, Aye T, Tansey MJ, White NH; Diabetes Research in Children Network (DirecNet).

Pediatr Diabetes. 2018 Apr 19. doi: 10.1111/pedi.12683. [Epub ahead of print]

10.

Persistence of abnormalities in white matter in children with type 1 diabetes.

Fox LA, Hershey T, Mauras N, Arbeláez AM, Tamborlane WV, Buckingham B, Tsalikian E, Englert K, Raman M, Jo B, Shen H, Reiss A, Mazaika P; Diabetes Research in Children Network (DirecNet).

Diabetologia. 2018 Jul;61(7):1538-1547. doi: 10.1007/s00125-018-4610-6. Epub 2018 Apr 13.

11.

Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations.

Klein KO, Rosenfield RL, Santen RJ, Gawlik AM, Backeljauw PF, Gravholt CH, Sas TCJ, Mauras N.

J Clin Endocrinol Metab. 2018 May 1;103(5):1790-1803. doi: 10.1210/jc.2017-02183. Review.

PMID:
29438552
12.

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.

Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Söderström-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF; International Turner Syndrome Consensus Group.

Eur J Endocrinol. 2017 Sep;177(3):G1-G70. doi: 10.1530/EJE-17-0430. Review.

PMID:
28705803
13.

Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes.

Canas JA, Gidding SS, Mauras N.

Curr Diabetes Rev. 2017;13(6):544-554. doi: 10.2174/1573399813666170113142621. Review.

PMID:
28088892
14.

Does oral glutamine improve insulin sensitivity in adolescents with type 1 diabetes?

Torres-Santiago L, Mauras N, Hossain J, Weltman AL, Darmaun D.

Nutrition. 2017 Feb;34:1-6. doi: 10.1016/j.nut.2016.09.003. Epub 2016 Sep 20.

15.

Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.

Mauras N, Ross JL, Gagliardi P, Yu YM, Hossain J, Permuy J, Damaso L, Merinbaum D, Singh RJ, Gaete X, Mericq V.

J Clin Endocrinol Metab. 2016 Dec;101(12):4984-4993. Epub 2016 Oct 6.

16.

Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes.

Saggar M, Tsalikian E, Mauras N, Mazaika P, White NH, Weinzimer S, Buckingham B, Hershey T, Reiss AL; Diabetes Research in Children Network (DirecNet).

Diabetes. 2017 Mar;66(3):754-762. doi: 10.2337/db16-0414. Epub 2016 Oct 4.

17.

Safety of using real-time sensor glucose values for treatment decisions in adolescents with poorly controlled type 1 diabetes mellitus: a pilot study.

Fox LA, Balkman E, Englert K, Hossain J, Mauras N.

Pediatr Diabetes. 2017 Jun;18(4):271-276. doi: 10.1111/pedi.12404. Epub 2016 Jul 20.

18.

Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes.

Hosseini SM, Mazaika P, Mauras N, Buckingham B, Weinzimer SA, Tsalikian E, White NH, Reiss AL; Diabetes Research in Children Network (DirecNet).

Hum Brain Mapp. 2016 Nov;37(11):4034-4046. doi: 10.1002/hbm.23293.

19.

Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months.

Cato MA, Mauras N, Mazaika P, Kollman C, Cheng P, Aye T, Ambrosino J, Beck RW, Ruedy KJ, Reiss AL, Tansey M, White NH, Hershey T; Diabetes Research in Children Network.

J Int Neuropsychol Soc. 2016 Mar;22(3):293-302. doi: 10.1017/S1355617715001289. Epub 2016 Jan 20.

20.

Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes.

Mazaika PK, Weinzimer SA, Mauras N, Buckingham B, White NH, Tsalikian E, Hershey T, Cato A, Aye T, Fox L, Wilson DM, Tansey MJ, Tamborlane W, Peng D, Raman M, Marzelli M, Reiss AL; Diabetes Research in Children Network (DirecNet).

Diabetes. 2016 Feb;65(2):476-85. doi: 10.2337/db15-1242. Epub 2015 Oct 28.

21.

Proceedings from the Turner Resource Network symposium: the crossroads of health care research and health care delivery.

Backeljauw PF, Bondy C, Chernausek SD, Cernich JT, Cole DA, Fasciano LP, Foodim J, Hawley S, Hong DS, Knickmeyer RC, Kruszka P, Lin AE, Lippe BM, Lorigan GA, Maslen CL, Mauras N, Page DC, Pemberton VL, Prakash SK, Quigley CA, Ranallo KC, Reiss AL, Sandberg DE, Scurlock C, Silberbach M.

Am J Med Genet A. 2015 Sep;167A(9):1962-71. doi: 10.1002/ajmg.a.37121. Epub 2015 Apr 29.

22.

Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States.

Bullinger M, Sommer R, Pleil A, Mauras N, Ross J, Newfield R, Silverman L, Rohenkohl A, Fox J, Quitmann J.

Health Qual Life Outcomes. 2015 Apr 2;13:43. doi: 10.1186/s12955-015-0236-2.

23.

Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls.

Mauras N, Santen RJ, Colón-Otero G, Hossain J, Wang Q, Mesaros C, Blair IA.

J Clin Endocrinol Metab. 2015 Jun;100(6):2322-8. doi: 10.1210/jc.2015-1495. Epub 2015 Apr 9. Erratum in: J Clin Endocrinol Metab. 2016 May;101(5):2267.

24.

Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype.

Rosenfield RL, DiMeglio LA, Mauras N, Ross J, Shaw ND, Greeley SA, Haymond M, Rubin K, Rhodes ET.

J Clin Endocrinol Metab. 2015 Apr;100(4):1234-6. doi: 10.1210/jc.2014-3845.

25.

Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus.

McCulloch MA, Mauras N, Canas JA, Hossain J, Sikes KM, Damaso LC, Redheuil A, Ross JL, Gidding SS.

Pediatr Diabetes. 2015 Mar;16(2):90-7. doi: 10.1111/pedi.12241. Epub 2014 Dec 18.

26.

Persistently high glucose levels in young children with type 1 diabetes.

Tansey M, Beck R, Ruedy K, Tamborlane W, Cheng P, Kollman C, Fox L, Weinzimer S, Mauras N, White NH, Tsalikian E; Diabetes Research in Children Network (DirecNet).

Pediatr Diabetes. 2016 Mar;17(2):93-100. doi: 10.1111/pedi.12248. Epub 2014 Dec 11.

27.

Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia.

Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, Hershey T, Cato A, Cheng P, Kollman C, Beck RW, Ruedy K, Aye T, Fox L, Arbelaez AM, Wilson D, Tansey M, Tamborlane W, Peng D, Marzelli M, Winer KK, Reiss AL; Diabetes Research in Children Network (DirecNet).

Diabetes. 2015 May;64(5):1770-9. doi: 10.2337/db14-1445. Epub 2014 Dec 8.

28.

A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes.

Canas JA, Ross JL, Taboada MV, Sikes KM, Damaso LC, Hossain J, Caulfield MP, Gidding SS, Mauras N.

Pediatr Diabetes. 2015 Mar;16(2):79-89. doi: 10.1111/pedi.12245. Epub 2014 Nov 22.

PMID:
25418907
29.

36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.

Lee PA, Klein K, Mauras N, Lev-Vaisler T, Bacher P.

J Clin Endocrinol Metab. 2014 Sep;99(9):3153-9. doi: 10.1210/jc.2013-4471. Epub 2014 Jun 13.

PMID:
24926950
30.

Cognitive functioning in young children with type 1 diabetes.

Cato MA, Mauras N, Ambrosino J, Bondurant A, Conrad AL, Kollman C, Cheng P, Beck RW, Ruedy KJ, Aye T, Reiss AL, White NH, Hershey T; Diabetes Research in Children Network (DirecNet).

J Int Neuropsychol Soc. 2014 Feb;20(2):238-47. doi: 10.1017/S1355617713001434.

31.

Alterations in white matter structure in young children with type 1 diabetes.

Barnea-Goraly N, Raman M, Mazaika P, Marzelli M, Hershey T, Weinzimer SA, Aye T, Buckingham B, Mauras N, White NH, Fox LA, Tansey M, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL; Diabetes Research in Children Network (DirecNet).

Diabetes Care. 2014 Feb;37(2):332-40. doi: 10.2337/dc13-1388. Epub 2013 Dec 6.

32.

Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes.

Marzelli MJ, Mazaika PK, Barnea-Goraly N, Hershey T, Tsalikian E, Tamborlane W, Mauras N, White NH, Buckingham B, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL; Diabetes Research in Children Network (DirecNet).

Diabetes. 2014 Jan;63(1):343-53. doi: 10.2337/db13-0179. Epub 2013 Oct 29.

33.

High success rates of sedation-free brain MRI scanning in young children using simple subject preparation protocols with and without a commercial mock scanner--the Diabetes Research in Children Network (DirecNet) experience.

Barnea-Goraly N, Weinzimer SA, Ruedy KJ, Mauras N, Beck RW, Marzelli MJ, Mazaika PK, Aye T, White NH, Tsalikian E, Fox L, Kollman C, Cheng P, Reiss AL; Diabetes Research in Children Network (DirecNet).

Pediatr Radiol. 2014 Feb;44(2):181-6. doi: 10.1007/s00247-013-2798-7. Epub 2013 Oct 6.

34.

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus.

Arbelaez AM, Xing D, Cryer PE, Kollman C, Beck RW, Sherr J, Ruedy KJ, Tamborlane WV, Mauras N, Tsalikian E, Wilson DM, White NH; Diabetes Research in Children Network (DirecNet) Study Group.

Pediatr Diabetes. 2014 Mar;15(2):127-34. doi: 10.1111/pedi.12070. Epub 2013 Aug 28.

35.

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Scholl UI, Goh G, Stölting G, de Oliveira RC, Choi M, Overton JD, Fonseca AL, Korah R, Starker LF, Kunstman JW, Prasad ML, Hartung EA, Mauras N, Benson MR, Brady T, Shapiro JR, Loring E, Nelson-Williams C, Libutti SK, Mane S, Hellman P, Westin G, Åkerström G, Björklund P, Carling T, Fahlke C, Hidalgo P, Lifton RP.

Nat Genet. 2013 Sep;45(9):1050-4. doi: 10.1038/ng.2695. Epub 2013 Aug 4.

36.

Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.

Torres-Santiago L, Mericq V, Taboada M, Unanue N, Klein KO, Singh R, Hossain J, Santen RJ, Ross JL, Mauras N.

J Clin Endocrinol Metab. 2013 Jul;98(7):2716-24. doi: 10.1210/jc.2012-4243. Epub 2013 May 15.

37.

Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Tansey M, Weinzimer S, Beck R, Ruedy K, Cheng P, Tamborlane W, Kollman C, Mauras N, Fox L, Coffey J, White NH; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2013 May;36(5):e63. doi: 10.2337/dc12-2021. No abstract available.

38.

Estrogen therapy in Turner syndrome: does the type, dose and mode of delivery matter?

Mauras N, Torres-Santiago L, Taboada M, Santen R.

Pediatr Endocrinol Rev. 2012 May;9 Suppl 2:718-22. Review.

PMID:
22946283
39.

Continuous glucose monitoring in type 1 diabetes.

Mauras N, Fox L, Englert K, Beck RW.

Endocrine. 2013 Feb;43(1):41-50. doi: 10.1007/s12020-012-9765-1. Epub 2012 Aug 28. Review.

PMID:
22926738
40.

Lipoprotein subfractions by ion mobility in lean and obese children.

Benson M, Hossain J, Caulfield MP, Damaso L, Gidding S, Mauras N.

J Pediatr. 2012 Dec;161(6):997-1003. doi: 10.1016/j.jpeds.2012.05.060. Epub 2012 Jul 20.

PMID:
22819275
41.

Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.

Mauras N, DelGiorno C, Hossain J, Bird K, Killen K, Merinbaum D, Weltman A, Damaso L, Balagopal P.

J Pediatr Endocrinol Metab. 2012;25(1-2):33-40.

42.

Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.

Lee PA, Klein K, Mauras N, Neely EK, Bloch CA, Larsen L, Mattia-Goldberg C, Chwalisz K.

J Clin Endocrinol Metab. 2012 May;97(5):1572-80. doi: 10.1210/jc.2011-2704. Epub 2012 Feb 16.

PMID:
22344198
43.

Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.

Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, Buckingham B, White NH, Arbelaez AM, Beck RW, Kollman C, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2012 Apr;35(4):817-20. doi: 10.2337/dc11-2190. Epub 2012 Feb 8.

44.

A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2012 Feb;35(2):204-10. doi: 10.2337/dc11-1746. Epub 2011 Dec 30.

45.

Lifestyle intervention improves fitness independent of metformin in obese adolescents.

Rynders C, Weltman A, Delgiorno C, Balagopal P, Damaso L, Killen K, Mauras N.

Med Sci Sports Exerc. 2012 May;44(5):786-92. doi: 10.1249/MSS.0b013e31823cef5e.

46.

Strategies for maximizing growth in puberty in children with short stature.

Mauras N.

Pediatr Clin North Am. 2011 Oct;58(5):1167-79, x. doi: 10.1016/j.pcl.2011.07.007. Review.

PMID:
21981954
47.

Acute changes in blood glucose do not alter blood glutathione synthesis in adolescents with poorly controlled type 1 diabetes mellitus.

Darmaun D, Welch S, Smith S, Sweeten S, Mauras N.

Metabolism. 2012 Mar;61(3):373-8. doi: 10.1016/j.metabol.2011.07.015. Epub 2011 Sep 23.

PMID:
21944270
48.

Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome.

Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, Mauras N.

J Clin Endocrinol Metab. 2011 Nov;96(11):3502-10. doi: 10.1210/jc.2011-1449. Epub 2011 Aug 31.

49.

Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial.

Wilson DM, Xing D, Cheng J, Beck RW, Hirsch I, Kollman C, Laffel L, Lawrence JM, Mauras N, Ruedy KJ, Tsalikian E, Wolpert H; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.

Diabetes Care. 2011 Jun;34(6):1315-7. doi: 10.2337/dc10-1661. Epub 2011 Apr 19.

50.

The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.

Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group.

Pediatr Diabetes. 2011 Dec;12(8):690-5. doi: 10.1111/j.1399-5448.2011.00764.x. Epub 2011 Apr 17.

Supplemental Content

Loading ...
Support Center